Key substance for treatment of visceral leishmaniasis identified
A study shows that stimulating the production of interleukin-17A (IL-17A), one of the cytokines released by cells of the immune system, can be an effective strategy for the treatment of visceral leishmaniasis, considered ...
Aug 25, 2016
0
0